Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
About this item
Full title
Author / Creator
Rueangweerayut, Ronnatrai , Phyo, Aung Pyae , Uthaisin, Chirapong , Poravuth, Yi , Binh, Tran Quang , Tinto, Halidou , Pénali, Louis K , Valecha, Neena , Tien, Nong Thi , Abdulla, Salim , Borghini-Fuhrer, Isabelle , Duparc, Stephan , Shin, Chang-Sik , Fleckenstein, Lawrence and Pyronaridine–Artesunate Study Team
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
New therapies to treat malaria are needed. In this report, in which the authors studied 1271 patients from Asia and Africa, pyronaridine–artesunate was found to be noninferior to mefloquine plus artesunate in the treatment of uncomplicated
Plasmodium falciparum
malaria.
Artemisinin-based combination therapy is critical for the effective tr...
Alternative Titles
Full title
Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_992862020
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_992862020
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1007125
